Drug Shortage Report for ENALAPRILAT INJECTION USP
Report ID | 231317 |
Drug Identification Number | 02388499 |
Brand name | ENALAPRILAT INJECTION USP |
Common or Proper name | ENALAPRILAT INJECTION USP |
Company Name | HIKMA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | ENALAPRILAT |
Strength(s) | 1.25MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 2mL vial |
ATC code | C09AA |
ATC description | ACE INHIBITORS, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-07-12 |
Actual start date | |
Estimated end date | 2025-01-31 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-11-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5995 AVEBURY ROAD, SUITE 804 MISSISSAUGA, ONTARIO CANADA L5R 3P9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2024-11-13 | French | Compare |
v6 | 2024-11-13 | English | Compare |
v5 | 2024-10-11 | French | Compare |
v4 | 2024-10-11 | English | Compare |
v3 | 2024-07-13 | English | Compare |
v2 | 2024-06-26 | French | Compare |
v1 | 2024-06-26 | English | Compare |
Showing 1 to 7 of 7